ASN 2024 Poster: EL-PFDD v SONG: PKDOC, the PKD Foundation, and the ARPKD community hosted an Externally-led Patient Focused Drug Development (EL-PFDD) meeting on
February 3, 2025 Living with Huntington’s Disease: A Conversation on Advocacy, Mental Health, and Self-Care I recently had the privilege of sitting down with Lauren Holder, Producer and Host of the Help 4 HD podcast, who is also a caregiv
January 31, 2025 Integrating Complex In Vitro Models Into the Regulatory Pipeline C-Path has developed a framework to support FDA qualification of CIVMs for use in regulatory submissions.
January 28, 2025 TRxA Funding Opportunities 2025 On January 28, C-Path’s Translational Therapeutics Accelerator (TRxA)...
January 23, 2025 C-Path Announces Jennifer Kendra as New Vice President of Strategic Relationships New Leadership to Drive Expansion of Collaborative Initiatives and Fundraising Strategies at C-Path
February 20, 2025 Vivli and RDCA-DAP Present: Data Platform Partnerships to promote Rare Disease Data Sharing Join Julie Wood, Chief Operating Officer at Vivli, for an engaging webinar, Thursday, February 20, where she’ll discuss...
January 21, 2025 Save the Date: CGIC Returns to D.C. this September We are thrilled to invite you to the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC)...
January 17, 2025 FDA Accepts Qualification Plan for Urine Biomarker Panel to Allow Earlier Detection of Response to Drug-Induced Kidney Injury in Clinical Trials The Foundation for the National Institutes of Health (FNIH) and Critical Path Institute® (C-Path)...
January 17, 2025 CP-RND ALS Public-Private Partnership Public Forum A public forum for stakeholders Critical Path Institute's (C-Path) Critical Path for Rare and Neurodegenerative Diseases...
January 15, 2025 C-Path Welcomes Bayer Pharma as Newest Member of CPP C-Path is excited to welcome Bayer Pharma as a the newest member of the organization's Critical Path for Parkinson’s (CPP)...